Delivery Order SPE2DB22D1202-SPE2DB25FUSY7
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.00 firm fixed price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,583.28, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.28 Firm Fixed Price delivery order is for COPAXONE 40 MG/ML SYRINGEML, a specialty medication, with a period of performance through November 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $2,474.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type. The period of performance runs through September 27, 2024. The contract is not set aside. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award, valued at $1,583.28, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of COPAXONE 40 MG/ML 12S, a pharmaceutical product, to support defense and civilian healthcare providers. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 20 MG/ML SYRINGE, a specialty medication, with a ceiling value of $2,441.40 and a completion date of January 9, 2024. The award is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp is a large, for-profit...
The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,583.28 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564466149 COPAXONE 40 MG/ML SYRINGEML and has a performance period through May 2, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award, with a ceiling value of $12,053.49, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a firm fixed price delivery order for the supply of COPAXONE 40 MG/ML SYRINGES, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
This federal contract award, worth $2,893.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML 12S, a pharmaceutical product, with a period of performance through December 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,583.28 firm-fixed-price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a prescription medication, to the agency. The contract has an ultimate completion date of May 7, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, through...